Evidence map›Paper›PMID 42844404›Full record

ArticleThe EMBO journal2026

Reciprocal coupling between EMT and BMP morphogen signalling drives collective cell invasion.

Yuri Takahashi, Alexandra Neaverson, Lara Busby, Filip Twarowski, Carlos Camacho-Macorra, Guillermo Serrano Nájera, Benjamin Steventon

Abstract read
PubMed Publisher
In one paragraph

Article in The EMBO journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yuri TakahashiDepartment of Genetics, University of Cambridge, Cambridge, CB2 3EH, UK.
Alexandra NeaversonDepartment of Genetics, University of Cambridge, Cambridge, CB2 3EH, UK.
Lara BusbyDepartment of Genetics, University of Cambridge, Cambridge, CB2 3EH, UK.ORCID http://orcid.org/0000-0003-0705-1364
Filip TwarowskiDepartment of Genetics, University of Cambridge, Cambridge, CB2 3EH, UK.
Carlos Camacho-MacorraDepartment of Genetics, University of Cambridge, Cambridge, CB2 3EH, UK.ORCID http://orcid.org/0000-0001-9916-896X
Guillermo Serrano NájeraDepartment of Genetics, University of Cambridge, Cambridge, CB2 3EH, UK.
Benjamin SteventonDepartment of Genetics, University of Cambridge, Cambridge, CB2 3EH, UK. bjs57@cam.ac.uk.ORCID http://orcid.org/0000-0001-7838-839X

Funding

Wellcome Trust (WT) 225360_Z_22_Z
6 · The paper itself

Abstract

During collective cell invasion, epithelial-to-mesenchymal transition (EMT) and morphogen signalling-mediated cell fate specification are traditionally viewed as a linear cascade: morphogens drive cell fates that activate EMT gene expression programs. Here, we uncover reciprocal coupling between EMT initiation and BMP signalling mediated by SNAI2 and SMAD1. Using ex vivo chick tissue explants, we demonstrate that substrate-induced migration upregulates SMAD1 expression, activating BMP signalling across germ layers. Single-cell RNA sequencing reveals SNAI2 and SMAD1 co-expression in EMT initiation regions, and SNAI2 overexpression is sufficient to induce ectopic SMAD1 expression in vivo. Ex vivo CRISPR-Cas9 experiments further demonstrate that SNAI2 is required for SMAD1 expression and BMP signalling. While BMP signalling is dispensable for EMT initiation, it regulates cell fate proportions, dispersal dynamics, precursor region depletion rates, and migration directionality. This coupling provides a mechanism for synchronising cell fate specification with invasion progression during axis elongation, positioning SNAI2-SMAD1 interaction as mechanism to coordinate cell fate specification and EMT during collective cell invasion.

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.